CoChat

Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways

Open access
Kim, Arianna L., Zhu, Yucui, Zhu, Huijie, Han, Lydia, Kopelovich, Levy, Bickers, David R., Athar, Mohammad · 2006 · Experimental Dermatology
Cited by 98

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Resveratrol (trans‐3,4′,5‐trihydroxystilbene) is a naturally occurring polyphenolic phytoalexin found in grapes, and has been shown to inhibit the growth of various types of cancer cells. We investigated the mechanism of the antiproliferative effect of resveratrol in A431‐transformed keratinocytes harbouring mutant p53, and show that it is accompanied by G1 cell cycle arrest, which coincides with a marked inhibition of G1 cell cycle regulatory proteins, including cyclins A and D1 and cyclin‐dependent kinase (CDK)6 and p53‐independent induction of p21WAF1. Cell cycle arrest was also associated with the accumulation of hypophosphorylated Rb and p27KIP1. Resveratrol inhibited mitogen‐activated protein kinase/extracellular signal‐regulated kinase kinase (MEK)1 > extracellular signal‐regulated protein kinase (ERK)1/2 signalling, downregulated c‐Jun, and suppressed activating protein (AP)‐1 DNA‐binding and promoter activity. In addition, the inhibition of MEK1 > ERK1/2 signalling appears to be independent of retinoblastoma protein (pRb) hypophosphorylation in A431 cells, as PD098059 did not suppress pRb phosphorylation. Our results demonstrate that resveratrol affects multiple cellular targets in A431 cells, and that the downregulation of both AP‐1 and pRb contributes to its antiproliferative activity in these cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-0625.2006.00445.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 38

  1. 10.1358/dnp.2003.16.5.829318 · DOI · Paper page
  2. 10.1016/0009-8981(96)06236-5 · DOI · Paper page
  3. 10.1016/S0024-3205(97)00883-7 · DOI · Paper page
  4. 10.1016/S0006-2952(98)00350-5 · DOI
  5. Aggarwal B B, 2004, Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res, 24, 2783
  6. Jang M, 1999, Cancer chemopreventive activity of resveratrol, Drugs Exp Clin Res, 25, 65
  7. 10.2741/afaq · DOI · Paper page
  8. 10.1159/000064533 · DOI · Paper page
  9. 10.1096/fj.04-3582fje · DOI · Paper page
  10. Marks R, 1995, Skin cancer, Recogn Treat Drugs, 50, 48
  11. 10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N · doi:10.1002/1096-9896(2000)9999:9999<::aid-path815>3.0.co;2-n
  12. 10.1562/0031-8655(2002)0750058SSAOCE2.0.CO2 · DOI
  13. 10.1046/j.1523-1747.2002.01734.x · DOI
  14. 10.1016/0092-8674(90)90395-U · DOI · Paper page
  15. 10.1101/gad.13.5.607 · DOI · Paper page
  16. 10.1182/blood.V79.8.2107.bloodjournal7982107 · DOI
  17. 10.1016/S0092-8674(00)00193-8 · DOI · Paper page
  18. 10.1073/pnas.96.17.9827 · DOI · Paper page
  19. 10.1038/sj.onc.1203603 · DOI · Paper page
  20. 10.1128/MCB.23.13.4494-4510.2003 · DOI · Paper page
  21. 10.1093/carcin/19.5.765 · DOI
  22. 10.1093/carcin/20.2.193 · DOI
  23. 10.1091/mbc.8.2.287 · DOI · Paper page
  24. 10.1073/pnas.92.17.7686 · DOI · Paper page
  25. 10.1074/jbc.273.29.18623 · DOI · Paper page
  26. 10.1016/S0165-6147(00)01865-4 · DOI · Paper page
  27. 10.1016/S0955-0674(97)80068-3 · DOI · Paper page
  28. 10.1074/jbc.M306614200 · DOI · Paper page
  29. 10.1007/0-306-48158-8_9 · DOI · Paper page
  30. Suyama H, 2004, ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells, Int J Oncol, 24, 1499
  31. 10.1111/j.0906-6705.2005.00317.x · DOI
  32. 10.1124/mol.104.006023 · DOI
  33. 10.1128/MCB.11.9.4466 · DOI · Paper page
  34. 10.1128/MCB.11.5.2451 · DOI · Paper page
  35. 10.1002/jcb.240550410 · DOI
  36. Herber B, 1994, Inducible regulatory elements in the human cyclin D1 promoter, Oncogene, 9, 2105
  37. 10.1074/jbc.274.48.34186 · DOI · Paper page
  38. 10.1128/MCB.18.9.5609 · DOI · Paper page

Cited by

See all 98

Metadata

Authors
Kim, A. L., Zhu, Y., Zhu, H., Han, L., Kopelovich, L., Bickers, D. R., & Athar, M.
Venue
Experimental Dermatology
Publisher
Wiley
Published
2006-06-02
Volume
15
Issue
7
Pages
538-546
ISSN
  • 0906-6705 (ISSN-L)
  • 1600-0625
OpenAlex
W2161809170
Cited by
98
References
1
FWCI
4.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways. https://app.cochat.ai/papers/10.1111/j.1600-0625.2006.00445.x
The paper
Kim, A. L., Zhu, Y., Zhu, H., Han, L., Kopelovich, L., Bickers, D. R., & Athar, M. (2006). Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways. Experimental Dermatology. https://doi.org/10.1111/j.1600-0625.2006.00445.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.